25 May 2013
Keywords: final, phase, ii, data, biomira, theratope, canada
Article | 18 November 1996
- Final Phase II data with Biomira of Canada's vaccine Theratope
(Stn-KLH), for patients with metastatic or recurrent breast cancer, show
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
24 May 2013
© 2013 thepharmaletter.com